1-2 of 2
Madeleine Dupont
Close
Sort by
Journal Articles

Prospective Multicentric Molecular Study for Poor Prognosis Fusion Transcripts at Diagnosis in Adult ALL Patients - The LALA94 Experience.

Jean A. Gabert, MD, PhD, Christophe Picard, MD, PhD, Sandrine Hayette, PhD, Christelle Bilhou-Nabera, MD, PhD, Jean-Michel Cayuela, PharmD, PhD, Elizabeth Macintyre, MD, PhD, Nicole Frenoy, PhD, Claude Preudhomme, PharmD, Madeleine DuPont, PhD, Christian Bastard, MD, Dominique Bories, MD, Jean-Paul Vaerman, PhD, Frédéric Davi, MD, PhD, Nicole Dastugue, MD, Sophie Raynaud, MD, Marina Lafage, MD, Thierry Fest, PhD, Marie-Pierre Gaub, PhD, Véronique Lheritier, Xavier Thomas, MD, Christiane Charrin, MD, Claude Boucheix, PhD, Hervé Dombret, MD, Denis Fiere, MD
Journal: Blood
Blood (2005) 106 (11): 4476.
https://doi.org/10.1182/blood.V106.11.4476.4476
Published: 2005
Journal Articles

Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951

Clinical Trials & Observations
Hélène Cavé, Stefan Suciu, Claude Preudhomme, Bruce Poppe, Alain Robert, Anne Uyttebroeck, Michèle Malet, Patrick Boutard, Yves Benoit, Laurent Mauvieux, Patrick Lutz, Françoise Méchinaud, Nathalie Grardel, Françoise Mazingue, Madeleine Dupont, Geneviève Margueritte, Marie-Pierre Pages, Yves Bertrand, Emmanuel Plouvier, Ghislaine Brunie, Christian Bastard, Dominique Plantaz, Isabel Vande Velde, Anne Hagemeijer, Frank Speleman, Michel Lessard, Jacques Otten, Etienne Vilmer, Nicole Dastugue, the EORTC-CLG
Journal: Blood
Blood (2004) 103 (2): 442–450.
https://doi.org/10.1182/blood-2003-05-1495
Published: 2004